ClinicalTrials.gg
Not yet recruitingNCT07863492Updated Oct 7, 2026

The Effect of Curve Type Determined According to the Rigo Classification on Respiratory Muscle Strength, Quality of Life, and Functional Status in Individuals Diagnosed With Adolescent Idiopathic Scoliosis.

An observational study in Scoliosis, Respiratory Function and Rigo Classification, sponsored by Istanbul Physical Medicine Rehabilitation Training and Research Hospital. Not yet recruiting. Open to participants aged 12 Years to 18 Years. Per ClinicalTrials.gov, last updated 2026-10-07.

Sponsored by Istanbul Physical Medicine Rehabilitation Training and Research Hospital · Observational

How we know

Updated Oct 7, 2026Newly registeredGo to Updates ↓

Help build ClinicalTrials.gg — short surveys, remote interviews or testing, in your language. Take part →

Study type
Observational
Model
Case-control
Time perspective
Cross-sectional
Enrollment
120
Ages
12 Years to 18 Years
Sex
All
01

Study summary

Adolescent Idiopathic Scoliosis (AIS) is a disorder that occurs between the ages of 10 and 18, with an unknown etiology, and is characterized by a three-dimensional deformity of the spine. It is often asymptomatic at onset but may progressively lead to cosmetic and functional impairments over time. The Rigo classification, which evaluates the structural characteristics of scoliosis, is a three-dimensional functional classification system that takes into account the direction of the curve and the involved spinal regions

In studies conducted on individuals with AIS, a significant reduction in respiratory muscle strength (MIP-Maximum Inspiratory Pressure and MEP-Maximum Expiratory Pressure) has been observed, and this condition has been associated with thoracic rigidity and decreased physical activity . In individuals with AIS, a significant negative correlation has been reported between Cobb angle and FVC and FEV₁ values, as well as a moderate negative correlation between trunk rotation angle (ATR) and respiratory muscle strength (MIP and MEP). In light of these findings, it has been shown that as the severity of scoliosis increases, lung volumes decrease, and that scoliosis may affect respiration not only through a two-dimensional curvature angle but also through three-dimensional structural changes such as trunk rotation. Curves concentrated in the thoracic region according to the Rigo classification demonstrate more pronounced reductions in MIP and MEP values

The impact of AIS on quality of life has been evaluated, and it has been reported that individuals with AIS score lower than healthy individuals in domains such as body image, pain, mental health, and function

02

Conditions studied

  • Scoliosis
  • Respiratory Function
  • Rigo Classification
  • MIP
  • MEP

Browse trials for

03

In context

Scoliosis

660 studies on the registry are indexed under Scoliosis; 185 are open to participants now.

This study's planned enrollment of 120 is above the median of 84 across 256 observational studies indexed under Scoliosis.

Browse Scoliosis studies →

Lead sponsor

Istanbul Physical Medicine Rehabilitation Training and Research Hospital is the lead sponsor of 123 studies on the registry; 26 are open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
12 Years to 18 Years
Sexes eligible
All
Sampling method
Probability sample

Study population

A total of 96 patients diagnosed with scoliosis who meet the study criteria and 24 healthy individuals will be selected from among those admitted to the Physical Medicine and Rehabilitation Clinic of the University of Health Sciences Istanbul Physical Therapy and Rehabilitation Training and Research Hospital SUAM.

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

Individuals with a Cobb angle greater than 10° and less than 60° (scoliosis group) Volunteers with a trunk rotation angle (ATR) of less than 5° measured by scoliometer and a negative Adam's test (control group) Aged between 12 and 18 years No history of surgical intervention due to scoliosis Ability to understand and respond to questions Literate individuals Individuals who provide themselves and whose families also give consent to participate in the study

Exclusion criteria

Exclusion Criteria:

Individuals under 12 years of age and over 18 years of age Individuals with conditions that hinder communication (hearing or speech impairments, accompanying intellectual disabilities, or inability to cooperate) Individuals with neurological, muscular, or rheumatologic diseases, or a history of previous spinal surgery Individuals who are not literate Individuals who do not volunteer to participate

Terms in these criteria, in plain language(1)

Underlined terms in the criteria open these too. Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.

Informed consent

Before you join, the study team explains what taking part involves — its purpose, what happens, the risks and possible benefits — and answers your questions, so you can decide freely. Consent is usually recorded on a form (the informed consent form, ICF) signed by you or, where the law allows, by someone legally authorized to decide for you.

You can keep asking questions during the study, you are told of new information that matters, and you can choose to leave at any time.

05

Study design

Observational model
Case-control
Time perspective
Cross-sectional
Enrollment
120 participants (estimated)
Patient registry
No
06

What researchers measure

Primary outcomes

  1. MIP,MEP,"Curve type according to the Rigo classification"

    Time frame: 6 Month

07

Study locations

No study locations are listed for this record.

08

References and documents

Individual participant data

Plan to share: Undecided

No publications or documents are linked to this record.

09

Timeline

1 registry update since Sep 25, 2026
ElapsedEstimatedEstimated, not yet reached

Start is estimated for Sep 2026; primary completion for Jan 2027, 4 months later.

How these figures are worked out, and which studies are left out of them.

Registered
Oct 2, 2026
First posted
Oct 7, 2026
StartEst.
Sep 15, 2026
Primary completionEst.
Jan 2027
CompletionEst.
Feb 2027
Last update
Oct 7, 2026
What these dates mean
Start.
When the first participant enrolled; while estimated, when the study expects to open to recruitment.
Primary completion.
When the last participant was examined or treated to collect data for the study's main question, its primary outcome. A study that stopped early gives the date its data collection stopped.
Completion.
When the last participant's last visit took place, for every outcome, secondary ones and side effects included: the end of the study. Often later than primary completion, sometimes the same day.
Actual and Est.
Actual means the registry says the date has happened. Est. (estimated) is a date the sponsor plans or expects. It can still move, and the sponsor is expected to change it to actual once it has passed.
Registered
First appeared on the registry. No changes since
Oct 7, 2026
Show all 1 update
  1. Oct 7, 2026
    First appeared on the registry

From the registry record's own update history. This site started tracking changes on Sep 25, 2026; for anything earlier, see the record history on ClinicalTrials.gov ↗

10

Registry details

Key details

Study ID
NCT07863492
Responsible party
Sponsor
First posted
Oct 7, 2026
Start date
Sep 15, 2026 (estimated)
Primary completion
Jan 2027 (estimated)
Completion
Feb 2027 (estimated)
Last update
Oct 7, 2026

Oversight

FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is not yet recruiting, as verified in Oct 2026. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion